独活寄生汤对膝骨关节炎大鼠IL-17/NF-κB通路的影响

被引:27
作者
张续
郑洁
赵莉平
安荣
何宇
邸晓洁
机构
[1] 陕西中医药大学
关键词
膝骨关节炎; 独活寄生汤; 白细胞介素17; NF-κB信号通路; 炎症因子;
D O I
暂无
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
目的:探讨独活寄生汤通过调控IL-17/NF-κB信号通路治疗膝骨关节炎(KOA)的作用机制。方法:将大鼠随机分为正常组、模型组、独活寄生汤组和双醋瑞因组,采用关节腔注射碘乙酸钠溶液建立KOA模型。确认造模成功后,分别采用药物干预30 d,观察大鼠膝关节软骨病理形态变化。酶联免疫吸附试验(ELISA)检测大鼠血清中白细胞介素17(IL-17)和肿瘤坏死因子α(TNF-α)的表达。Real-time PCR和免疫组化法检测软骨核因子κB p65(NF-κB p65)、肿瘤坏死因子受体相关因子6(TRAF6)、NF-κB激活剂1(ACT1) mRNA和蛋白表达水平。结果:独活寄生汤组大鼠膝关节软骨表面稍不平整,软骨细胞数量减少,排列较规则,软骨基质轻染。与正常组比较,模型组大鼠血清IL-17、TNF-α表达水平升高(均P<0.01)。与模型组比较,独活寄生汤组大鼠血清IL-17、TNF-α表达下降(均P<0.05)。与正常组比较,模型组TRAF6 mRNA表达升高,NF-κB p65、ACT1 mRNA表达升高(均P<0.01)。与模型组比较,独活寄生汤组NF-κB p65、ACT1、TRAF6 mRNA表达降低(均P<0.05)。与正常组比较,模型组大鼠软骨NF-κB p65、TRAF6和ACT1蛋白表达水平升高(均P<0.01)。与模型组比较,独活寄生汤组大鼠软骨NF-κB p65、TRAF6、ACT1的蛋白表达降低(均P<0.01)。结论:独活寄生汤通过调节IL-17/NF-κB信号通路,降低IL-17、TNF-α促炎因子表达,有效缓解KOA模型大鼠症状。
引用
收藏
页码:691 / 695
页数:5
相关论文
共 20 条
[1]
Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis [J].
Molnar, Vilim ;
Matisic, Vid ;
Kodvanj, Ivan ;
Bjelica, Roko ;
Jelec, Zeljko ;
Hudetz, Damir ;
Rod, Eduard ;
Cukelj, Fabijan ;
Vrdoljak, Trpimir ;
Vidovic, Dinko ;
Staresinic, Mario ;
Sabalic, Srecko ;
Dobricic, Borut ;
Petrovic, Tadija ;
Anticevic, Darko ;
Boric, Igor ;
Kosir, Rok ;
Zmrzljak, Ursula Prosenc ;
Primorac, Dragan .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
[2]
Inhibition of interleukin-17-induced effects in osteoarthritis - an in vitro study.[J].J.Y. Mimpen;A.J. Carr;S.G. Dakin;S.J. Snelling.Osteoarthritis and Cartilage.2018,
[3]
Therapeutics in Osteoarthritis Based on an Understanding of Its Molecular Pathogenesis [J].
Kim, Ju-Ryoung ;
Yoo, Jong Jin ;
Kim, Hyun Ah .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (03)
[4]
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation..[J].Erika Terzuoli;Stefania Meini;Paola Cucchi;Claudio Catalani;Cecilia Cialdai;Carlo Alberto Maggi;Antonio Giachetti;Marina Ziche;Sandra Donnini.PLoS ONE.2017, 1
[5]
Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use [J].
Kraus, V. B. ;
Blanco, F. J. ;
Englund, M. ;
Karsdal, M. A. ;
Lohmander, L. S. .
OSTEOARTHRITIS AND CARTILAGE, 2015, 23 (08) :1233-1241
[6]
IL-17 family: Cytokines, receptors and signaling [J].
Gu, Chunfang ;
Wu, Ling ;
Li, Xiaoxia .
CYTOKINE, 2013, 64 (02) :477-485
[7]
Targeting IL-17and TH17 cells in chronic inflammation [J].
Miossec, Pierre ;
Kolls, Jay K. .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (10) :763-776
[8]
NF-κB Signaling: Multiple Angles to Target OA [J].
Marcu, Kenneth B. ;
Otero, Miguel ;
Olivotto, Eleonora ;
Borzi, Rosa Maria ;
Goldring, Mary B. .
CURRENT DRUG TARGETS, 2010, 11 (05) :599-613
[9]
Mono-iodoacetate-induced experimental osteoarthritis - A dose-response study of loss of mobility, morphology, and biochemistry [J].
Guingamp, C ;
GegoutPottie, P ;
Philippe, L ;
Terlain, B ;
Netter, P ;
Gillet, P .
ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1670-1679
[10]
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data..[J].Mankin H J;Dorfman H;Lippiello L;Zarins A.The Journal of bone and joint surgery. American volume.1971, 3